CHRW vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CHRW

61.8
AI Score
VS
CHRW Wins

XRAY

43.4
AI Score

Investment Advisor Scores

CHRW

62score
Recommendation
BUY

XRAY

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CHRW XRAY Winner
Forward P/E 17.5439 6.4392 XRAY
PEG Ratio 1.4984 0.6439 XRAY
Revenue Growth 29.5% -7.5% CHRW
Earnings Growth 24.6% 15.2% CHRW
Tradestie Score 61.8/100 43.4/100 CHRW
Profit Margin 3.7% -3.4% CHRW
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD CHRW

Relative Price Performance (Last 90 Days)

CHRW 1M: -4.0% · 3M: -11.3% XRAY 1M: +12.5% · 3M: -17.4%

Current Technical Phase

CHRW

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $132.42

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.3 · Price: $9.57

Fundamentals Snapshot

Metric CHRW XRAY
Market Cap — —
Forward P/E 17.3 7.7
Trailing P/E 22.5 —
Revenue (TTM) — —
Revenue Growth 0.3% -0.1%
Gross Margin 0.1% 0.5%
Operating Margin 0.1% 0.0%
EPS 5.73 -0.61
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CHRW is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.